论文部分内容阅读
目的 探讨抗严重急性呼吸综合征 (SARS)冠状病毒IgG抗体阳性与临床诊断的相关性及其治疗方法。方法 回顾性分析 35例血清IgG抗体阳性SARS患者临床资料。结果 SARS患者血清IgG抗体阳性检出率与病程呈正相关 ,≥ 30d的阳性率达 10 0 %。结论 抗SARS冠状病毒IgG抗体测定适应于发病 1周后SARS患者的辅助诊断 ,阴性者应追踪检测至第 4周后。SARS的治疗为综合治疗 ,其中糖皮质激素的用法待探讨
Objective To investigate the correlation between positive anti-SARS coronavirus IgG antibody and clinical diagnosis and the treatment of severe acute respiratory syndrome (SARS) coronavirus. Methods The clinical data of 35 patients with IgG antibody positive SARS were retrospectively analyzed. Results The positive rate of serum IgG antibody in patients with SARS was positively correlated with the course of disease, and the positive rate of serum IgG was 100% at ≥30 days. Conclusion The anti-SARS coronavirus IgG antibody is suitable for the auxiliary diagnosis of patients with SARS one week after the onset of disease, while the negative ones should be followed up to the fourth week. The treatment of SARS is a comprehensive treatment, in which the use of glucocorticoid to be explored